UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 129

Sortiert nach

Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539

Journal of neurosurgery, 2018-07, Vol.129 (1), p.35-47

2018

Volltextzugriff (PDF)

Gliadel wafer implantation combined with standard radiotherapy and concurrent followed by adjuvant temozolomide for treatment of newly diagnosed high-grade glioma: a systematic literature review

World journal of surgical oncology, 2016-08, Vol.14 (1), p.225-225, Article 225

2016

Volltextzugriff (PDF)

Phase III Randomized Trial Comparing the Efficacy of Cediranib As Monotherapy, and in Combination With Lomustine, Versus Lomustine Alone in Patients With Recurrent Glioblastoma

Journal of clinical oncology, 2013-09, Vol.31 (26), p.3212-3218

2013

Volltextzugriff (PDF)

An extent of resection threshold for recurrent glioblastoma and its risk for neurological morbidity

Journal of neurosurgery, 2014-04, Vol.120 (4), p.846-853

2014

Volltextzugriff (PDF)

High-risk Meningioma: Initial Outcomes From NRG Oncology/RTOG 0539

International journal of radiation oncology, biology, physics, 2020-03, Vol.106 (4), p.790-799

2020

Volltextzugriff (PDF)

Rindopepimut with Bevacizumab for Patients with Relapsed EGFRvIII-Expressing Glioblastoma (ReACT): Results of a Double-Blind Randomized Phase II Trial

Clinical cancer research, 2020-04, Vol.26 (7), p.1586-1594

2020

Volltextzugriff (PDF)

An extent of resection threshold for seizure freedom in patients with low-grade gliomas

Journal of neurosurgery, 2018-04, Vol.128 (4), p.1084-1090

2018

Volltextzugriff (PDF)

A randomized phase II study of everolimus in combination with chemoradiation in newly diagnosed glioblastoma: results of NRG Oncology RTOG 0913

Neuro-oncology (Charlottesville, Va.), 2018-04, Vol.20 (5), p.666-673

2018

Volltextzugriff (PDF)

Joint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials With Procarbazine, Lomustine, and Vincristine Chemotherapy for Anaplastic Oligodendroglial Tumors

Journal of clinical oncology, 2022-08, Vol.40 (23), p.2539-2545

2022

Volltextzugriff (PDF)

Low-risk meningioma: Initial outcomes from NRG Oncology/RTOG 0539

Neuro-oncology (Charlottesville, Va.), 2023-01, Vol.25 (1), p.137-145

2023

Volltextzugriff (PDF)

Phase 1/2 Trials of Temozolomide, Motexafin Gadolinium, and 60-Gy Fractionated Radiation for Newly Diagnosed Supratentorial Glioblastoma Multiforme: Final Results of RTOG 0513

International journal of radiation oncology, biology, physics, 2015-04, Vol.91 (5), p.961-967

2015

Volltextzugriff (PDF)

Atypical Teratoid Rhabdoid Tumor: Two Case Reports and an Analysis of Adult Cases with Implications for Pathophysiology and Treatment

Frontiers in neurology, 2017-06, Vol.8, p.247-247

2017

Volltextzugriff (PDF)

The impact of extent of resection on malignant transformation of pure oligodendrogliomas

Journal of neurosurgery, 2014-02, Vol.120 (2), p.309-314

2014

Volltextzugriff (PDF)

International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors

Neuro-oncology (Charlottesville, Va.), 2011-06, Vol.13 (6), p.649-659

2011

Volltextzugriff (PDF)

Whither thiotepa (for patients in the USA)?

Journal of neuro-oncology, 2015-09, Vol.124 (3), p.529-530

2015

Volltextzugriff (PDF)

Initial treatment patterns over time for anaplastic oligodendroglial tumors

Neuro-oncology (Charlottesville, Va.), 2012-06, Vol.14 (6), p.761-767

2012

Volltextzugriff (PDF)

NRG/RTOG 0837: Randomized, phase II, double-blind, placebo-controlled trial of chemoradiation with or without cediranib in newly diagnosed glioblastoma

Neuro-oncology advances, 2023-01, Vol.5 (1), p.vdad116-vdad116

2023

Volltextzugriff (PDF)

Magnetic resonance imaging volumetric assessment of the extent of contrast enhancement and resection in oligodendroglial tumors: Clinical article

Journal of neurosurgery, 2012-06, Vol.116 (6), p.1172-1181

2012

Volltextzugriff (PDF)

Magnetic resonance imaging volumetric assessment of the extent of contrast enhancement and resection in oligodendroglial tumors

Journal of neurosurgery, 2012-06, Vol.116 (6), p.1172-1181

2012

Volltextzugriff (PDF)

ATIM-03. ACT IV: AN INTERNATIONAL, DOUBLE-BLIND, PHASE 3 TRIAL OF RINDOPEPIMUT IN NEWLY DIAGNOSED, EGFRvIII-EXPRESSING GLIOBLASTOMA

Neuro-oncology (Charlottesville, Va.), 2016-11, Vol.18 (suppl_6), p.vi17-vi18

2016

Volltextzugriff (PDF)

Management of malignant glioma: steady progress with multimodal approaches

Neurosurgical focus, 2006-04, Vol.20 (4), p.E3

2006

Volltextzugriff (PDF)

Prospective trial of gross-total resection with Gliadel wafers followed by early postoperative Gamma Knife radiosurgery and conformal fractionated radiotherapy as the initial treatment for patients with radiographically suspected, newly diagnosed glioblastoma multiforme

Journal of neurosurgery, 2008-12, Vol.109 (Supplement), p.106-117

2008

Volltextzugriff (PDF)

Low-grade glioma: no longer to treat or not to treat, but why to treat

World neurosurgery, 2010, Vol.73 (1), p.e5-e5

Ashby, Lynn Stuart, MD

2010

Volltextzugriff (PDF)

1 – 25 von 129

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(94)
Mit Volltextzugriff
(116)

Publikationsform

Sprache

Englisch
(129)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

Humans
(43)
Life Sciences & Biomedicine
(41)
Science & Technology
(41)
Clinical Neurology
(26)
Female
(26)
Male
(26)
Neurosciences & Neurology
(26)
Oncology
(25)
Adult
(21)
Middle Aged
(21)
Surgery
(19)
Aged
(17)
Biological And Medical Sciences
(17)
Medical Sciences
(17)
Brain Neoplasms - Therapy
(14)
Neurosurgery
(14)
Surgery . Transplantations, Organ And Tissue Grafts. Graft Diseases
(12)
Neurology
(11)
Treatment Outcome
(11)
Prognosis
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539

Gliadel wafer implantation combined with standard radiotherapy and concurrent followed by adjuvant temozolomide for treatment of newly diagnosed high-grade glioma: a systematic literature review

Phase III Randomized Trial Comparing the Efficacy of Cediranib As Monotherapy, and in Combination With Lomustine, Versus Lomustine Alone in Patients With Recurrent Glioblastoma

An extent of resection threshold for recurrent glioblastoma and its risk for neurological morbidity

High-risk Meningioma: Initial Outcomes From NRG Oncology/RTOG 0539

Rindopepimut with Bevacizumab for Patients with Relapsed EGFRvIII-Expressing Glioblastoma (ReACT): Results of a Double-Blind Randomized Phase II Trial

An extent of resection threshold for seizure freedom in patients with low-grade gliomas

A randomized phase II study of everolimus in combination with chemoradiation in newly diagnosed glioblastoma: results of NRG Oncology RTOG 0913

Joint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials With Procarbazine, Lomustine, and Vincristine Chemotherapy for Anaplastic Oligodendroglial Tumors

Association of MGMT Promoter Methylation Status With Survival Outcomes in Patients With High-Risk Glioma Treated With Radiotherapy and Temozolomide: An Analysis From the NRG Oncology/RTOG 0424 Trial

Low-risk meningioma: Initial outcomes from NRG Oncology/RTOG 0539

Phase 1/2 Trials of Temozolomide, Motexafin Gadolinium, and 60-Gy Fractionated Radiation for Newly Diagnosed Supratentorial Glioblastoma Multiforme: Final Results of RTOG 0513

Atypical Teratoid Rhabdoid Tumor: Two Case Reports and an Analysis of Adult Cases with Implications for Pathophysiology and Treatment

Independently validated sex-specific nomograms for predicting survival in patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825

The impact of extent of resection on malignant transformation of pure oligodendrogliomas

International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors

Whither thiotepa (for patients in the USA)?

Initial treatment patterns over time for anaplastic oligodendroglial tumors

NRG/RTOG 0837: Randomized, phase II, double-blind, placebo-controlled trial of chemoradiation with or without cediranib in newly diagnosed glioblastoma

Magnetic resonance imaging volumetric assessment of the extent of contrast enhancement and resection in oligodendroglial tumors: Clinical article

Magnetic resonance imaging volumetric assessment of the extent of contrast enhancement and resection in oligodendroglial tumors

ATIM-03. ACT IV: AN INTERNATIONAL, DOUBLE-BLIND, PHASE 3 TRIAL OF RINDOPEPIMUT IN NEWLY DIAGNOSED, EGFRvIII-EXPRESSING GLIOBLASTOMA

Management of malignant glioma: steady progress with multimodal approaches

Prospective trial of gross-total resection with Gliadel wafers followed by early postoperative Gamma Knife radiosurgery and conformal fractionated radiotherapy as the initial treatment for patients with radiographically suspected, newly diagnosed glioblastoma multiforme

Low-grade glioma: no longer to treat or not to treat, but why to treat

Suchergebnisse filtern